These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 495560)

  • 21. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ; Washington JA
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The microbiologic activity of cephalothin, cephalexin, cephacetrile, cephradine, cephazolin and cephamandol].
    Knothe H; Lauer B
    Adv Clin Pharmacol; 1974; 8():80-8. PubMed ID: 4468733
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative beta-lactamase resistance and antistaphylococcal activities of parenterally and orally administered cephalosporins.
    Farrar WE; O'Dell NM
    J Infect Dis; 1978 Apr; 137(4):490-3. PubMed ID: 649992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
    Jones RN; Barry AL; Pfaller M; Allen SD; Ayers LW; Fuchs PC
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):59-63. PubMed ID: 3370932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.
    Fung-Tomc JC; Huczko E; Stickle T; Minassian B; Kolek B; Denbleyker K; Bonner D; Kessler R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):533-8. PubMed ID: 7726528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Larsson P; Lincoln K; Lind L; Sandberg T
    Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of clinical isolates of gram-positive and gram-negative organisms to cefatrizine.
    Carlone NA; Cuffini AM; Forno Pizzoglio M; Cavallo G
    Drugs Exp Clin Res; 1985; 11(7):447-51. PubMed ID: 3836867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of LY163892, cefaclor, and cefuroxime.
    Knapp CC; Washington JA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):131-3. PubMed ID: 3348605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autobac I procedure to assess susceptibility to Cefaclor.
    Gröschel D; Mills K; Hopfer RL
    J Clin Microbiol; 1980 Jun; 11(6):660-3. PubMed ID: 7430335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility studies with cefaclor and cephalexin.
    Scheld WM; Korzeniowski OM; Sande MA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):290-2. PubMed ID: 900924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bactericidal activity of cefadroxil, cephalexin, and cephradine in an in vitro pharmacokinetic model.
    Leitner F; Goodhines RA; Buck RE; Price KE
    J Antibiot (Tokyo); 1979 Jul; 32(7):718-26. PubMed ID: 541265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro activity of 4 cephalosporins on gram-negative bacteria and Staphylococcus aureus of hospital origin].
    Herrera N; Silva J; Godoy J; Urdanivia R; Becerra S; Jofre M
    Rev Med Chil; 1985 Apr; 113(4):329-33. PubMed ID: 3835642
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of BMY-28100, a new oral cephalosporin.
    Eliopoulos GM; Reiszner E; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro studies with cefaclor, a new oral cephalosporin.
    Sanders C
    Antimicrob Agents Chemother; 1977 Oct; 12(4):490-7. PubMed ID: 921244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concept of class in relation to first-generation cephalosporins].
    De Toffoli A; Fantin B; Vechiet D
    Quad Sclavo Diagn; 1984 Jun; 20(2):181-6. PubMed ID: 6441962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
    Jones RN; Barry AL
    J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
    Levison ME; Santoro J; Agarwal BN
    Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.